Literature DB >> 8826970

Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

W Suarez-Pinzon1, R V Rajotte, T R Mosmann, A Rabinovitch.   

Abstract

Syngeneic pancreatic islet grafts in diabetic NOD mice are infiltrated by mononuclear leukocytes, beta-cells are selectively destroyed, and autoimmune diabetes recurs. This model was used to identify islet graft-infiltrating mononuclear leukocytes associated with beta-cell destruction and diabetes recurrence. We compared cell surface antigen and cytokine-producing phenotypes of mononuclear leukocytes in islet grafts from NOD mice that were protected from diabetes recurrence by complete Freund's adjuvant (CFA) administration (beta-cell nondestructive insulitis) and in islet grafts from control phosphate-buffered saline (PBS)-injected NOD mice (beta-cell destructive insulitis). Islet grafts from CFA-injected mice contained fewer CD4+ and CD8+ cells and more B cells; also fewer interferon gamma (IFN-gamma), interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF-alpha)-positive cells and more IL-4 and IL-10 positive cells. By performing two-color immunostaining of cell surface antigens and intracellular IFN-gamma, we found that IFN-gamma positive cells in islet grafts from CFA- and PBS-injected mice were approximately equally divided between CD4+ and CD8+ T-cell subsets. Also, the frequencies of both CD4+ IFN-gamma + and CD8+ IFN-gamma + cells were decreased in islet grafts from CFA-injected mice. These findings suggest that destruction of beta-cells in syngeneic islets transplanted into NOD mice is promoted by cells producing Th1-type cytokines (IFN-gamma, IL-2, and TNF-alpha) and prevented by cells producing TH2-type cytokines (IL-4 and IL-10). Furthermore, both CD4+ and CD8+ IFN-gamma-producing T-cells in the islet grafts appear to be involved in beta-cell destruction and diabetes recurrence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826970     DOI: 10.2337/diab.45.10.1350

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Positive evidence for vitamin A role in prevention of type 1 diabetes.

Authors:  Somaye Yosaee; Maryam Akbari Fakhrabadi; Farzad Shidfar
Journal:  World J Diabetes       Date:  2016-05-10

2.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

3.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

4.  Ultrathin polymeric coatings based on hydrogen-bonded polyphenol for protection of pancreatic islet cells.

Authors:  Veronika Kozlovskaya; Oleksandra Zavgorodnya; Yi Chen; Kristin Ellis; Hubert M Tse; Wanxing Cui; J Anthony Thompson; Eugenia Kharlampieva
Journal:  Adv Funct Mater       Date:  2012-04-30       Impact factor: 18.808

5.  Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse.

Authors:  G Kuriya; T Uchida; S Akazawa; M Kobayashi; K Nakamura; T Satoh; I Horie; E Kawasaki; H Yamasaki; L Yu; Y Iwakura; H Sasaki; Y Nagayama; A Kawakami; N Abiru
Journal:  Diabetologia       Date:  2013-05-23       Impact factor: 10.122

6.  Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

Authors:  Feng-Cheng Chou; Shing-Hwa Huang; Huey-Kang Sytwu
Journal:  Int J Endocrinol       Date:  2012-05-29       Impact factor: 3.257

7.  Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis.

Authors:  Nils E Magnusson; Alessandra K Cardozo; Mogens Kruhøffer; Decio L Eizirik; Torben F Ørntoft; Jens L Jensen
Journal:  BMC Bioinformatics       Date:  2005-12-29       Impact factor: 3.169

8.  All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

Authors:  Yang-Hau Van; Wen-Hui Lee; Serina Ortiz; Mi-Heon Lee; Han-Jun Qin; Chih-Pin Liu
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.